SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
2.160
0.00 (0.00%)
At close: Aug 13, 2025, 4:00 PM
2.150
-0.010 (-0.46%)
After-hours: Aug 13, 2025, 4:00 PM EDT
SAB Biotherapeutics Market Cap
SAB Biotherapeutics has a market cap or net worth of $22.49 million as of August 13, 2025. Its market cap has decreased by -12.98% in one year.
Market Cap
22.49M
Enterprise Value
23.19M
1-Year Change
-12.98%
Ranking
Category
Stock Price
$2.16
Market Cap Chart
Since February 9, 2021, SAB Biotherapeutics's market cap has decreased from $130.75M to $22.49M, a decrease of -82.80%. That is a compound annual growth rate of -32.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 22.49M | -35.78% |
| Dec 31, 2024 | 35.02M | -44.79% |
| Dec 29, 2023 | 63.43M | 113.36% |
| Dec 30, 2022 | 29.73M | -91.24% |
| Dec 31, 2021 | 339.54M | 159.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 582.58B |
| Johnson & Johnson | 417.34B |
| AbbVie | 348.59B |
| UnitedHealth Group | 230.35B |
| AstraZeneca | 227.85B |
| Abbott Laboratories | 227.74B |
| Novartis AG | 225.61B |
| Novo Nordisk | 224.34B |